Profil

Gordenne Valérie

Département de pharmacie > Pharmacie galénique

See author's contact details
Main Referenced Co-authors
Foidart, Jean-Michel  (2)
Mawet, Marie  (2)
Coelingh Bennink, Herjan J T (1)
Enache, Andrea (1)
Frankenne, Francis (1)
Main Referenced Keywords
Adult (1); Aged (1); Double-Blind Method (1); Endometrial Hyperplasia (1); Estetrol (1);
Main Referenced Disciplines
Reproductive medicine (gynecology, andrology, obstetrics) (2)

Publications (total 2)

The most downloaded
57 downloads
Mawet, M., Nollevaux, F., Nizet, D., Wijzen, F., Gordenne, V., Tasev, N., Segedi, D., Marinescu, B., Enache, A., Parhomenko, V., Frankenne, F., & Foidart, J.-M. (2014). Impact of a New Levonorgestrel Intrauterine System, Levosert(®), on Heavy Menstrual Bleeding: Results of a One-Year Randomised Controlled Trial. European Journal of Contraception and Reproductive Health Care. doi:10.3109/13625187.2014.894184 https://hdl.handle.net/2268/248680

The most cited

32 citations (Scopus®)

GASPARD, U., Taziaux, M., Mawet, M., Jost, M., Gordenne, V., Coelingh Bennink, H. J. T., Lobo, R. A., Utian, W. H., & Foidart, J.-M. (August 2020). A multicenter, randomized study to select the minimum effective dose of estetrol (E4) in postmenopausal women (E4Relief): part 1. Vasomotor symptoms and overall safety. Menopause (New York, N.Y.), 27 (8), 848-857. doi:10.1097/GME.0000000000001561 https://hdl.handle.net/2268/291318

GASPARD, U., Taziaux, M., Mawet, M., Jost, M., Gordenne, V., Coelingh Bennink, H. J. T., Lobo, R. A., Utian, W. H., & Foidart, J.-M. (August 2020). A multicenter, randomized study to select the minimum effective dose of estetrol (E4) in postmenopausal women (E4Relief): part 1. Vasomotor symptoms and overall safety. Menopause (New York, N.Y.), 27 (8), 848-857. doi:10.1097/GME.0000000000001561
Peer reviewed

Mawet, M., Nollevaux, F., Nizet, D., Wijzen, F., Gordenne, V., Tasev, N., Segedi, D., Marinescu, B., Enache, A., Parhomenko, V., Frankenne, F., & Foidart, J.-M. (2014). Impact of a New Levonorgestrel Intrauterine System, Levosert(®), on Heavy Menstrual Bleeding: Results of a One-Year Randomised Controlled Trial. European Journal of Contraception and Reproductive Health Care. doi:10.3109/13625187.2014.894184
Peer Reviewed verified by ORBi

Contact ORBi